Renaissance Technologies
COLL icon

Renaissance Technologies’s Collegium Pharmaceutical COLL Stock Holding History

Renaissance Technologies’s Portfolio COLL Stock Details COLL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$48.6M Sell
1,469,449
-147,900
-9% -$6.26M 0.08% 334
2025
Q4 		$74.9M Buy
1,617,349
+18,160
+1% +$760K 0.12% 202
2025
Q3 		$56M Buy
1,599,189
+78,019
+5% +$2.71M 0.07% 312
2025
Q2 		$45M Sell
1,521,170
-94,879
-6% -$2.71M 0.06% 378
2025
Q1 		$48.2M Sell
1,616,049
-45,500
-3% -$1.39M 0.07% 335
2024
Q4 		$47.6M Buy
1,661,549
+5,480
+0.3% +$181K 0.07% 340
2024
Q3 		$64M Buy
1,656,069
+124,571
+8% +$4.44M 0.1% 253
2024
Q2 		$49.3M Buy
1,531,498
+113,300
+8% +$3.93M 0.08% 298
2024
Q1 		$55.1M Buy
1,418,198
+33,600
+2% +$1.18M 0.09% 285
2023
Q4 		$42.6M Buy
1,384,598
+212,000
+18% +$5.31M 0.07% 342
2023
Q3 		$26.2M Sell
1,172,598
-102,400
-8% -$2.34M 0.04% 459
2023
Q2 		$27.4M Buy
1,274,998
+66,500
+6% +$1.51M 0.04% 527
2023
Q1 		$29M Buy
1,208,498
+54,179
+5% +$1.44M 0.04% 546
2022
Q4 		$26.8M Sell
1,154,319
-86,499
-7% -$1.74M 0.04% 583
2022
Q3 		$19.9M Sell
1,240,818
-156,000
-11% -$2.75M 0.03% 679
2022
Q2 		$24.8M Buy
1,396,818
+126,700
+10% +$2.13M 0.03% 626
2022
Q1 		$25.9M Buy
1,270,118
+13,800
+1% +$261K 0.03% 622
2021
Q4 		$23.5M Sell
1,256,318
-48,679
-4% -$949K 0.03% 630
2021
Q3 		$25.8M Buy
1,304,997
+55,479
+4% +$1.2M 0.03% 559
2021
Q2 		$29.5M Sell
1,249,518
-16,200
-1% -$374K 0.04% 540
2021
Q1 		$30M Sell
1,265,718
-117,000
-8% -$2.78M 0.04% 559
2020
Q4 		$27.7M Sell
1,382,718
-47,700
-3% -$931K 0.03% 597
2020
Q3 		$29.8M Sell
1,430,418
-196,900
-12% -$3.55M 0.03% 563
2020
Q2 		$28.5M Buy
1,627,318
+40,700
+3% +$797K 0.02% 638
2020
Q1 		$25.9M Buy
1,586,618
+334,290
+27% +$6.9M 0.03% 651
2019
Q4 		$25.8M Buy
1,252,328
+505,128
+68% +$8.42M 0.02% 865
2019
Q3 		$8.58M Buy
747,200
+503,100
+206% +$5.74M 0.01% 1485
2019
Q2 		$3.21M Buy
+244,100
New +$3.26M ﹤0.01% 2080
2018
Q2 		– Sell
-13,500
Closed -$345K – 3291
2018
Q1 		$345K Sell
13,500
-117,300
-90% -$2.79M ﹤0.01% 3024
2017
Q4 		$2.42M Buy
+130,800
New +$1.87M ﹤0.01% 2234
2016
Q1 		– Sell
-11,933
Closed -$328K – 3386
2015
Q4 		$328K Sell
11,933
-19,867
-62% -$419K ﹤0.01% 2860
2015
Q3 		$703K Buy
+31,800
New +$575K ﹤0.01% 2516

Other funds holding COLL

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Fuller & Thaler Asset Management
Fuller & Thaler Asset Management San Mateo, California $29.7B AUM 43.33% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
EAM
Eventide Asset Management Boston, Massachusetts $6.05B AUM 76.64% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Principal Financial Group
Principal Financial Group Des Moines, Iowa $187B AUM 18.48% 1-Year Est. Return
RCMNY
Rubric Capital Management (New York) New York $9.44B AUM 68.42% 1-Year Est. Return

Renaissance Technologies's COLL Position: Q1 2026 in Review

Renaissance Technologies reduced its Collegium Pharmaceutical (COLL) stake by 9.1% in Q1 2026, selling an estimated $6.26M and leaving 1,469,449 shares worth $48.6M. The position accounts for 0.08% of the portfolio, ranked #334.

Renaissance Technologies first reported a position in COLL in Q3 2015 and has held it in 32 quarters since. The position peaked at $74.9M in Q4 2025. 266 funds tracked by Wall St. Rank hold COLL as of Q1 2026.

  • Renaissance Technologies held 1,469,449 shares of Collegium Pharmaceutical worth $48.6M as of Q1 2026.
  • Renaissance Technologies sold 147,900 Collegium Pharmaceutical shares in Q1 2026, an estimated $6.26M.
  • Collegium Pharmaceutical made up 0.08% of Renaissance Technologies's portfolio in Q1 2026, its #334 holding.
  • Renaissance Technologies first reported a position in Collegium Pharmaceutical in Q3 2015 and has held it in 32 quarters since.
  • Renaissance Technologies's Collegium Pharmaceutical position peaked at $74.9M in Q4 2025.
  • 266 funds tracked by Wall St. Rank held Collegium Pharmaceutical as of Q1 2026.

Based on Renaissance Technologies's 13F filing for Q1 2026, filed 14 May 2026.